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Summary
Quinine (QN) remains effective against Plasmodium
falciparum, but its decreasing efficacy is documented
from different continents. Multiple genes are likely to
contribute to the evolution of QN resistance. To locate
genes contributing to QN response variation, we have
searched a P. falciparum genetic cross for quantitative
trait loci (QTL). Results identify additive QTL in segments of chromosomes (Chrs) 13, 7 and 5, and pairwise effects from two additional loci of Chrs 9 and 6
that interact, respectively, with the QTL of Chrs 13 and
7. The mapped segments of Chrs 7 and 5 contain pfcrt,
the determinant of chloroquine resistance (CQR), and
pfmdr1, a gene known to affect QN responses. Association of pfcrt with a QTL of QN resistance supports
anecdotal evidence for an evolutionary relationship
between CQR and reduced QN sensitivity. The Chr 13
segment contains several candidate genes, one of
which (pfnhe-1) encodes a putative Na+/H+ exchanger.
A repeat polymorphism in pfnhe-1 shows significant
association with low QN response in a collection of
P. falciparum strains from Asia, Africa and Central and
South America. Dissection of the genes and modifiers
involved in QN response will require experimental
strategies that can evaluate multiple genes from different chromosomes in combination.
Introduction
Quinine (QN), an alkaloid from cinchona bark, is a critical
and widely used drug because of its efficacy against
severe and chloroquine-resistant (CQR) malaria (World
.
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Health Organization, 2000). Yet the status of this drug is
in jeopardy because of decreases in the dose responsiveness of Plasmodium falciparum infections in regions of
south-east Asia, South America and Africa (Pukrittayakamee et al., 1994; Jelinek et al., 1995; Segurado et al.,
1997).
Reports that decreased QN sensitivity can be associated with resistance to other structurally related
drugs such as mefloquine, halofantrine and chloroquine (CQ) have led to suggestions that some heritable determinants of drug response may be shared
(Simon et al., 1986; Warsame et al., 1991; Basco and
Le Bras, 1992; Brasseur et al., 1992). Work in recent
years has pointed to two such genes. One is the
pfmdr1 gene that encodes a P. falciparum P-glycoprotein-like protein (Pgh-1) implicated in mefloquine and
halofantrine resistance, and also a possible modulator
of the CQR phenotype (Cowman et al., 1994; Reed
et al., 2000). The other is pfcrt, the actual determinant
of CQR, which can carry mutations associated with
stereospecific changes in quinine and quinidine
responses (Fidock et al., 2000; Cooper et al., 2002).
Although selection and transfection experiments have
implicated these genes in QN response, their relative
contribution to the trait and the way in which they
interact with each other and additional genes to
generate the specific drug response have not been
elucidated.
QN
nevertheless
remains
clinically
effective
against CQR and mefloquine-resistant P. falciparum. These observations and the different levels
of QN susceptibility among CQR parasites indicate
that the QN phenotype is complex and is probably
affected by other genes in addition to pfmdr1 and
pfcrt (Mu et al., 2003). Searches for loci carrying
these genes are possible through statistical methods developed to dissect complex quantitative trait
loci (QTL) (Lander and Botstein, 1989; Paterson,
1995; Sen and Churchill, 2001). P. falciparum
genetic crosses can be subjected to genome-wide
scans for individual QTL-containing genes that affect
the resistance phenotype.
Here, we report a QTL analysis of QN responses inherited in cloned parasite progeny from a P. falciparum cross.
We address the genetic determinants of the QN
responses of these parasites, including three additive and
two pairwise QTL interactions.
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Results

A

Quantitative drug response traits of the HB3 ¥ Dd2
parents and progeny
The parasites for this study were taken from the P. falciparum genetic cross between HB3, a CQ-sensitive (CQS)
clone from Central America, and Dd2, a CQR clone of
south-east Asian provenance (Wellems et al., 1990).
Table 1 summarizes quantitative traits of the QN and CQ
responses of the HB3 and Dd2 parent clones, including
their QN and CQ IC50 and IC90 values, response slope
parameters (Hill 3 curve-fit ‘b’) and IC90 values after verapamil (VP) chemosensitization. The values for the Dd2
clone are in the range of QN susceptibilities that our
assays typically yield for culture-adapted parasites from
areas where difficulties with QN treatment have been
reported, including the W2 and W2-MEF ancestors of the
Dd2 clone and other drug-resistant parasite lines from the
Amazon and Indochina (Oduola et al., 1988; Pukrittayakamee et al., 1994; Zalis et al., 1998; Mu et al., 2003; Pickard et al., 2003). The response curves and Hill slope bparameters of QN response for each parent were reproducible with high precision in more than 50 separate [3H]hypoxanthine incorporation assays. The mean b-parameters did not differ significantly between the HB3 and Dd2
clones (2.2 and 2.3, respectively, for QN).
Quantitative trait values for the QN and CQ responses
of 35 independent recombinant progeny from the
HB3 ¥ Dd2 cross, based on the results of 7–22 separate
assays, are provided in Supplementary material
(Table S1). The QN b-parameters for the progeny were
found to range from a low of 1.5 to a high of 3.0, well
outside the parental values and indicating heritable components in the QN responses that impact the shape of the
dose–response curves and, consequently, the relative
information content of IC90 and IC50 values. Because
median IC90 values are more sensitive to slope variations,
these were used for subsequent QTL analyses to ensure
Table 1. Drug response traits of the HB3 and Dd2 P. falciparum
clones.a
Trait

Dd2 (n = 65)

HB3 (n = 53)

QN IC50
QN IC90
QN-VP IC90
QN slope b (Hill)
CQ IC50
CQ IC90
CQ-VP IC90
CQ slope b (Hill)

350
924
395
2.3
433
735
247
4.0

115
382
393
2.2
25
44
44
4.3

(334–368)
(826–1038)
(352–444)
(2.1–2.5)
(417–448)
(665–811)
(230–266)
(3.5–4.5)

(110–120)
(344–424)
(355–433)
(2.0–2.4)
(24–26)
(40–49)
(41–49)
(3.5–5.0)

a. QN and CQ responses of clones derived from curve-fitted values
(nM) from combined data of n dose–response assays. Confidence
intervals (95%) are shown in parentheses. QN-VP IC90 and CQ-VP
IC90 indicate responses to CQ and QN in the presence of 0.89 mM
VP. The slope of QN response curve (QN slope) is the b-parameter
calculated from the Hill 3 curve-fit equation.

B

Fig. 1. QN versus CQ responses of the HB3 ¥ Dd2 parents and
progeny in the absence and presence of VP.
A. In the absence of VP, the large gap distinguishing the CQR from
the CQS progeny is determined by inheritance of the pfcrt gene.
B. Chemosensitization by VP of QN and CQ responses occurs in
CQR but not in CQS progeny. Each of the progeny data points was
obtained from 7 to 22 independent dose–response assays. Results
from CQR clones are shown as filled circles; results from CQS clones
are shown as open circles. A concentration of 0.89 mM VP was used
in the chemosensitization experiments.

that this curve information was included in the dose–
response measure. The QN and CQ IC90 values of the
HB3 and Dd2 parents and progeny are plotted in Fig. 1.
CQ response values (y-axis) clearly demonstrate the
effect from pfcrt, i.e. there is a clear gap separating the
CQ IC90 values of CQS from CQR parasites (Fig. 1A). No
such gap is evident for the QN responses, which are
instead spread across a continuous range that extends to
either side of the low (HB3) and high (Dd2) parent QN IC90
values. Considerable overlap is evident in the QN
responses of CQS and CQR progeny, indicating a complex QN response trait involving multiple genes.
The QN IC90 values of the parasites were also examined
© 2004 Blackwell Publishing Ltd, Molecular Microbiology, 52, 985–997
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for shifts in the presence of VP, a compound that potentiates the effect of CQ on CQR parasites only (Martin et al.,
1987). The results show 30–70% VP chemosensitization
of the QN response (a shift to the left in the dose–
response curve) for the CQR but not the CQS parasites
(Fig. 1B). This effect of VP on QN response was strictly
associated with the CQR phenotype and the pfcrt mutant
allele, irrespective of the relative QN IC90 values.
Chemosensitization of the QN response by VP did not
occur in any of the CQS progeny.
Primary and secondary scans for additive QTL associated
with drug response
To search for chromosome regions involved in drug
responses of the HB3 ¥ Dd2 cross, we used the
Pseudomarker QTL analysis package (Sen and Churchill,
2001) to scan the 35 progeny for phenotype associations
with markers in the segregation tables of our reported
5 cM genome-wide linkage map (Su et al., 1999) (http://
www.ncbi.nlm.nih.gov/Malaria/Mapsmarkers/PfSegData/
segdata.html). The results of these scans indicated that
most of the QN response variation can be attributed to
two main additive QTL: 35% to a chromosome (Chr) 13
peak centred on the C13M56 marker, and another 30%
to a Chr 7 peak centred on the pfcrt gene (Fig. 2A).
After accounting for main effects of the Chr 7 and Chr
13 loci, we searched the remaining unassigned fraction of
QN response variation by secondary scans of the residual
variation (Doerge and Churchill, 1996). These scans
revealed a Chr 5 QTL that had not been evident in the
primary scan and accounted for 30% of the remaining
fraction (10.5% of total response variation). The peak
height corresponding to this secondary additive QTL
approaches the permutation-based significance threshold
of P = 0.05 (Fig. 2B). The pfmdr1 gene, previously associated with QN response in several studies (Reed et al.,
2000; Babiker et al., 2001), resides within this peak near
the B5M86 marker. Of interest, this Chr 5 peak is associated with increased QN IC90 when it is contributed by HB3,
the more sensitive parent. This is in contrast to the peaks
of Chr 7 and Chr 13, which are associated with increased
QN IC90 when they are contributed by the more resistant
Dd2 parent.
The contribution by the pfcrt-containing Chr 7 locus to
QN response is evident but relatively small compared with
a recently reported association in genetically heterogeneous parasite isolates from around the world (Mu et al.,
2003). Additionally, the modest effect from this locus on
QN response stands in stark contrast to its control of
nearly all the CQ response variation inherited in the
HB3 ¥ Dd2 progeny. Mutations in the Dd2 pfcrt account
for >95% of the CQ response variation and are associated
in a sharp peak with LOD > 20 (Fig. 2C). No statistically
© 2004 Blackwell Publishing Ltd, Molecular Microbiology, 52, 985–997

significant additional peaks were identified by secondary
scans of the residual variation in the CQ response after
adjustment for the CQR variance associated with pfcrt;
however, several smaller peaks that could possibly
account for 20% of this variation included a peak that
aligned with the major QN locus on Chr 13 (Fig. 1; data
not shown). It is possible that incremental contributions
from such minor loci to QN response levels could explain
the slight positive correlation in CQR levels and QN
response (Fig. 1A); such loci could carry incremental
resistance genes or may reflect a complex adaptive role
that different polymorphisms play in the CQR phenotype
conferred by pfcrt mutations (Wellems and Plowe, 2001).
VP chemosensitization of QN response determined solely
by pfcrt mutations
CQR may have features in common with P-glycoproteinmediated multiple drug resistance in mammalian tumour
cell lines (Krogstad et al., 1987; Martin et al., 1987). Subsequent reports suggested associations between various
quinoline antimalarial responses of P. falciparum and
mutations in the pfmdr1-encoded glycoprotein, Pgh-1
(reviewed by Bray and Ward, 1998); however, VP
chemosensitization of CQR parasites is associated specifically with pfcrt mutations (Fidock et al., 2000; Cooper
et al., 2002; Sidhu et al., 2002). To test further for genetic
associations to the chemosensitization effect, we performed genome scans on the changes in QN response
produced in the HB3 ¥ Dd2 progeny by VP. Results from
these scans showed that the VP chemosensitization of
QN response co-segregated exactly with the Chr 7 peak
containing the Dd2 pfcrt allele (Fig. 2D). Nearly 100% of
the VP affect was assigned to this peak, demonstrating
that, although pfcrt mutations do not alone account for QN
response, they completely determine the VP chemosensitization of QN response. Secondary residual and pairwise scans did not detect any effect from the Chr 5
segment carrying pfmdr1 or other QTL elsewhere in the
genome.
Candidate genes from the three additive QTL peaks
associated with QN response
The pfcrt and pfmdr1 genes that reside in the QTL peaks
of Chrs 7 and 5 have previously been implicated in the
QN responses of P. falciparum. For example, certain
mutations in pfcrt generated by in vitro selection experiments increase sensitivity to QN but reduce sensitivity to
its diastereomer, quinidine (Cooper et al., 2002); the
results of allelic exchange studies have also shown that
pfcrt modifications can affect QN responses (Sidhu et al.,
2002). Additionally, amplification of and site-specific
changes in pfmdr1 can alter QN responses (Cowman
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A

B

Fig. 2. Main QTL identified by one-dimensional
genome-wide scans.
A. Plot showing Chr 7 (pfcrt) and Chr 13
(C13M56) QTL associated with the QN IC90.
B. Chr 5 peak (B5M56) containing the pfmdr1
gene identified in secondary scan after removing effects of major QTL associated with markers C13M56 and pfcrt.
C. Mainscan plot showing the magnitude of the
effect from the pfcrt gene on CQ response
(Supplementary material, Table S1) previously
demonstrated to determine CQR in this cross
(Fidock et al., 2000).
D. Complete association of the pfcrt peak with
the VP chemosensitization phenotype, QN-VP
IC90.
Markers of the 14 chromosomal linkage groups
occur sequentially along the horizontal axes.
LOD scores are plotted as a function of genome
location. Dashed lines represent threshold values from 1000 permutations.

C

D

© 2004 Blackwell Publishing Ltd, Molecular Microbiology, 52, 985–997
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et al., 1994; Reed et al., 2000). The PfCRT and Pgh-1
transporter molecules encoded by these genes probably
underlie the QN response variation that maps to the Chr
7 and Chr 5 QTL peaks, although our study does not
exclude the possibility that QN response might also be
affected by other genes within these peaks.
The Chr 13 QTL peak did not immediately suggest a
polymorphism or gene previously reported to be associated with malaria drug responses. To search for candidate
genes, we used a Bayesian localization module (Sen
and Churchill, 2001) to generate a posterior distribution
spanning the position of this residual Chr 13 effect
between the subtelomeric region of the chromosome
(ta58 marker) and the proximal 164.5 cM marker, C13M14
[95% confidence interval (CI) ranging from ª170 cM to the
end of the chromosome] (http://www.ncbi.nlm.nih.gov/
Malaria/Mapsmarkers/PfSegData/ch13a.html).
The
nucleotide sequence spanning the QTL is a 380 kb
segment (Sanger Center sequence chr13-1 available at
http://plasmodb.org). Approximately 100 predicted genes
reside within this segment (Supplementary material,
Table S2).
Molecules that can affect pH gradients across the membranes of cellular compartments have been proposed to
have a role in responses to CQ and, by extension, to other
quinoline drugs. The A and B subunits of a vacuolar
ATPase (Karcz et al., 1993) and a sodium-hydrogen
exchanger (NHE) (Sanchez et al., 1998; Wunsch et al.,

1998) have been suggested as candidates for such a role.
Evidence for direct involvement of the A subunit in CQR
has been negative, however, and evidence for a primary
role of the NHE in CQR has been refuted (Bray et al.,
1999). We were therefore intrigued by the presence in the
Chr 13 QTL of the PF13_0034 gene, encoding putative
subunit H of a vacuolar ATP synthase, and gene
PF13_0019, encoding a predicted P. falciparum NHE
(PfNHE-1).
To test for an association of QN response variation to
either of these genes, we resequenced PF13_0034 and
PF13_0019 from the HB3 and Dd2 parents, identified
coding frame polymorphisms and surveyed these polymorphisms in 71 P. falciparum lines from south-east Asia,
Africa and Central and South America. In the putative ATP
synthase H subunit gene PF13_0034, most lines from
south-east Asia possessed a single codon #8 GGA (Gly)
polymorphism that was largely absent from African and
American lines. The presence or absence of this polymorphism did not, however, show any significant association
with QN response levels in our survey.
In contrast to the putative ATP synthase H subunit gene,
sequences of PfNHE-1 showed multiple and complex variations. In the 71 P. falciparum lines with different QN
responses, these variations were evident as point polymorphisms at three separate codons (790, 894, 950) and
as microsatellite variations in three different repeat
sequences (msR1, ms3580, ms4760) (Fig. 3A and B).

A

B

Fig. 3. Schematic diagram of PfNHE-1 and alignment of ms4760 microsatellite variations.
A. Features of the full open reading frame include a signal peptide cleavage site (predicted by the SIGNALP program; http://genome.cbs.dtu.dk/
services/) and 12 transmembrane segments in the downstream sequence (MEMSAT program; http://saier-144-37.ucsd.edu/). PfNHE-1 also
possesses a long C-terminal hydrophilic tail proposed to be a cytoplasmic domain; in related bacterial and mammalian exchangers, this domain
is thought to modulate transport activity (http://pfam.wustl.edu/ accession no. PF00999; Orlowski and Grinstein, 1997; Hamada et al., 2001).
Positions of codon polymorphisms 790, 894 and 950 in the hydrophilic tail segment are marked by asterisks; positions of microsatellite variations
msR1, ms 3580 and ms4760 are labelled. The drawing is scaled to the 1920-amino-acid sequence from the P. falciparum 3D7 gene (Pf13_0019;
http://www.plasmodb.org/).
B. Alignment of ms4760 sequences from different P. falciparum lines. Microsatellite variation ms4760-1, represented in the South American clone
7G8 and the south-east Asian clone Dd2, is the form associated with reduced QN sensitivity in the population surveys (Table 2). DNNND repeats
discussed in the text are highlighted in bold.
© 2004 Blackwell Publishing Ltd, Molecular Microbiology, 52, 985–997
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The three point polymorphisms and microsatellite polymorphisms msR1 and ms3580 showed no significant
association with QN response (Table 2). Variable D- and
N-rich repeats encoded by ms4760, however, showed an

identical form (ms4760-1; Fig. 3B) in the relatively
quinine-resistant Dd2 and 7G8 lines from south-east Asia
and South America; this same form also appeared frequently in other parasites with low QN responsiveness

Table 2. Relative QN responses and PfNHE polymorphisms in P. falciparum lines.
Point polymorphisms

Microsatellite polymorphisms

Isolate

Origin

QN responsea

790

894

950

msR1

ms3580

ms4760b

Indo
KMWII
PC15
FCB
JCK
V1/S
PC09
C2A
P31
D5
Dd2
TM191c
TM284
106/1
Thai19
PC26
DIV17
HB3
DIV14
ICS
M97
ECP
PC17
JAV
PC49
Fab6
7G8
Thai16
K39
123/5
128/4
9013
PAD
DIV30
124/8
M5
3D7
S35
M2
Fab9
ECU
Haiti
D10
REN
9020
4156
T2/c6
9016
102/1
M190
LF4/1
SL/D6
MR80
PNG3
425
224
713
418

Indochina
Kenya
Peru
SE Asia
Cambodia
Vietnam
Peru
Thailand
SE Asia
SE Asia
Indochina
Thailand
Thailand
Sudan
Thailand
Peru
Brazil
Honduras
Brazil
Brazil
The Gambia
Brazil
Peru
Colombia
Peru
South Africa
Brazil
Thailand
Kenya
Sudan
Sudan
Ghana
Brazil
Brazil
Sudan
Mali
Africa
Mali
R/Mali
South Africa
Ecuador81
Haiti
Papua New Guinea
Sudan
Ghana
The Gambia
Thailand
Ghana
Sudan
The Gambia
Liberia
Sierra Leone
Vietnam
Papua New Guinea
The Gambia
The Gambia
Guinea Bissau
The Gambia

3.02
2.28
1.75
1.61
1.45
1.26
1.15
1.14
1.12
1.12
1.00
0.98
0.94
0.85
0.82
0.71
0.67
0.63
0.57
0.55
0.55
0.52
0.51
0.50
0.46
0.42
0.39
0.35
0.35
0.35
0.32
0.31
0.28
0.28
0.27
0.27
0.25
0.23
0.23
0.22
0.21
0.21
0.20
0.17
0.17
0.17
0.17
0.16
0.16
0.15
0.14
0.14
0.13
0.13
0.13
0.13
0.13
0.12

GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
TTC
GTC
GTC
GTC
TTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC

AAT
AAT
AAT
AAA
AAT
AAT
AAT
AAT
AAA
AAA
AAA
AAA
AAA
AAA
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAA
AAT
AAA
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAA
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAA
AAT
AAT
AAT
AAT

GGG
GTG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GTG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GTG
GGG
GGG
GGG
GGG
GGG
GGG
GGG
GTG
GGG
GGG
GGG
GGG
GGG
GGG
GTG
GGG
GGG
GGG
GGG
GGG
GTG
GGG
GGG
GGG
GGG
GGG
GTG
GGG
GGG

TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
Not present
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
Not present
Not present
Not present
TCDNNNMPNNNMSNNN
Not present
Not present
Not present
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
Not present
TCDNNNMPNNNMSNNN
Not present
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
Not present
Not present
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
Not present
Not present
Not present
TCDNNNMPNNNMSNNN
Not present
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
Not present
Not present
Not present
TCDNNNMPNNNMSNNN
Not present
TCDNNNMPNNNMSNNN
Not present
Not present
Not present
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
Not present
TCDNNNMPNNNMSNNN

NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
Not present
Not present
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
Not present
NIH
NIH
NIH
NIH
NIH
NIH
Not present
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH

ms4760-7
ms4760-1
ms4760-1
ms4760-6
ms4760-1
ms4760-1
ms4760-1
ms4760-1
ms4760-6
ms4760-6
ms4760-1
ms4760-7
ms4760-1
ms4760-6
ms4760-7
ms4760-1
ms4760-1
ms4760-5
ms4760-1
ms4760-1
ms4760-3
ms4760-1
ms4760-1
ms4760-1
ms4760-6
ms4760-8
ms4760-1
ms4760-1
ms4760-3
ms4760-3
ms4760-1
ms4760-3
ms4760-3
ms4760-3
ms4760-8
ms4760-1
ms4760-2
ms4760-1
ms4760-1
ms4760-6
ms4760-7
ms4760-1
ms4760-7
ms4760-3
ms4760-1
ms4760-3
ms4760-3
ms4760-3
ms4760-1
ms4760-3
ms4760-1
ms4760-8
ms4760-7
ms4760-7
ms4760-1
ms4760-3
ms4760-7
ms4760-3

© 2004 Blackwell Publishing Ltd, Molecular Microbiology, 52, 985–997
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Table 2. cont.
Point polymorphisms

Microsatellite polymorphisms

Isolate

Origin

QN responsea

790

894

950

msR1

ms3580

ms4760b

M24
PNG13
449
9021
433
MT/s-1
Hu425
P13
PNG 2
PNG4
601
434
Camp

Kenya
Papua New Guinea
The Gambia
Ghana
The Gambia
Thailand
The Gambia
Mali
Papua New Guinea
Papua New Guinea
The Gambia
The Gambia
Malaysia

0.11
0.11
0.11
0.11
0.11
0.11
0.10
0.09
0.08
0.08
0.08
0.06
0.05

GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC
GTC

AAT
AAA
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAT
AAA
AAT

GGG
GGG
GTG
GGG
GTG
GGG
GGG
GGG
GGG
GGG
GGG
GAG
GTG

Not present
TCDNNNMPNNNMSNNN
Not present
Not present
Not present
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
Not present
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN
TCDNNNMPNNNMSNNN

NIH
Not present
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH
NIH

ms4760-3
ms4760-6
ms4760-3
ms4760-7
ms4760-1
ms4760-4
ms4760-1
ms4760-7
ms4760-7
ms4760-7
ms4760-3
ms4760-3
ms4760-3

a. QN responses are expressed as median IC90 values relative to that of the Dd2 control value.
b. Polymorphism types are detailed in Fig. 3.

from south-east Asia, South America and Africa (Table 2).
Other forms of the ms4760 region were more often found
in the relatively QN-sensitive lines (Table 2). These observations, and the fact that identical ms4760-1 variations
probably arose independently in the Dd2 and 7G8 drugresistant lines from south-east Asia and South America,
led us to examine the ms4760 variations in more detail.
Figure 3B shows an alignment of eight ms4760 types
among the 71 worldwide isolates listed in Table 2. The
insertions and deletions of degenerate repeats in this
alignment occur within an ª150 bp region of the coding
frame. When the parasite isolates were grouped by the
number of DNNND repeats in the ms4760 types, we found
a statistical association with QN response (F3,66 = 3.190,
P = 0.0082). Post hoc tests indicated that this relationship
could be attributed to differences in QN response between
isolates containing one versus two or more repeat units.
When only parasites were evaluated from Asia and South
America, where reduced clinical efficacy of quinine has
been most clearly documented, a relationship of quinine
responses and the number of DNNND repeats was still
observed (F1,30 = 4.485, P < 0.05).
Evidence for loci that interact with the Chr 13 and
Chr 7 QTL
The complexity of the QN response with respect to the
additive loci of Chrs 13, 7 and 5 and its significant but
incomplete association with PfNHE-1 repeat polymorphisms in some parasite lines led us to conduct additional
pairwise searches for interacting QTL. These interaction
effects can reveal QTL that show no effect alone, but
rather have an influence dependent on a second locus.
The pairwise scans, performed as described by Sen and
Churchill (2001), identified significant interactions on the
HB3 ¥ Dd2 background with the main QTL of Chrs 7 and
© 2004 Blackwell Publishing Ltd, Molecular Microbiology, 52, 985–997

13 (Fig. 4). These interactions were with chromosomes 6
and chromosomes 9 respectively. In each paired interaction, Chr 6 ¥ Chr 7 and Chr 9 ¥ Chr 13 (Table 3; Fig. 4),
the maximum effect of the main locus shifting the
responses higher was exerted when the interacting locus
was also from the Dd2 parent. No independent main
effects were detected for either of the Chr 6 and 9 loci
alone (Fig. 2A and B), and little impact of the interacting
locus was present if the main QTL was from the HB3
parent (Table 4, coef column; Fig. 4).
These observations suggest that gene interactions
could reflect either co-operative drug response genes or
compensatory mutations selected in the Dd2 parent
clone. Although we do not know how these pairs function, an observation is possibly relevant: prolonged cloning periods and slow in vitro expansion rates were
observed for the six independent recombinants with the
HB3-type Chr 6 QTL and the Dd2-type Chr 7 QTL (pfcrt),
which raises the possibility that parasite fitness is
affected by this QTL combination. An additional preliminary complex growth phenotype based on radiolabelled
hypoxanthine (Hx) incorporation as a growth indicator
shows a QTL on the same arm of Chr 13 as the QN
response locus (M. T. Ferdig, unpublished. observation).
Because our dose–response assays rely on Hx incorporation, we took steps to rule out the possibility that an
assay-specific artifact could be represented in the drug
response QTL scan: we conducted parallel drug assays
from a subset of nine progeny representing the range of
QN responses using the lactate dehydrogenase indicator
of parasite viability (Makler et al., 1993) and the standard
Hx tests (data not shown). We observed no difference in
the association between drug response and marker
C13M56 at the Chr 13 peak using these two methods.
Additionally, QTL mapping of another quinoline-based
antimalarial compound, mefloquine, using the Hx assay
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Fig. 4. Pairwise interactions located by diagonally symmetric signals in a two-dimensional
genome-wide scan.
A. Output from a simultaneous search at 5 cM
intervals for QTL pairs affecting QN IC90 in the
HB3 ¥ Dd2 cross. Markers in the 14 linkage
groups occur in order along the axes. The LOD
plot for a two-QTL model with interactions is
displayed below the diagonal; the vertical spectrum at the right shows the corresponding LOD
score colour code. For the pairwise plot below
the diagonal, the P = 0.05 significance threshold based on 1000 permutations is LOD = 6.9.
Significant interactions between Chrs 9 and 13
(LOD = 8.7) and between Chrs 6 and 7
(LOD = 7.1) are detected as bright yellow signals (arrows). Above and to the left of the diagonal is a plot of the difference in the variance
between an interactive two-QTL model and a
non-interactive, additive model. For this plot, a
nominal cut-off of P = 0.01 was used, and the
LOD score values were expanded by a factor
of three to enhance colour detection. Chr
6 ¥ Chr 7 and Chr 9 ¥ Chr 13 interactions are
indicated by the red signals diagonally symmetrical with those below the diagonal (LOD score
ª4; arrows).
B and C. Graphic representations of the interactive effects between the B5M74 and pfcrt
markers (Chr 6 ¥ Chr 7) and between the
C9M57 and C13M56 markers (Chr 9 ¥ Chr 13).
The inheritance of the Dd2 parent alleles at
each locus for each interaction results in substantially higher QN IC90 values than inheritance of other possible allele combinations.
Corresponding means, standard deviations and
pairwise comparisons are provided in Table 2.

A

B

C

are thought to exert similar toxic effects through interactions with haem in malaria parasite food vacuoles; however, the historical use of these major antimalarial drugs
and the consequent selection pressure on natural parasite
populations has been distinct. QN has been used in the
form of cinchona bark extracts or purified alkaloid prepa-

shows no peak in this region of Chr 13 (M. T. Ferdig,
unpublished observation).
Discussion
QN and CQ have related core quinoline structures and
Table 3. QN IC90 QTL positions and effects.

QTL

Chr

Effect

QN
QN
QN
QN
QN

13
7
5
6
9

Main
Main
Main
Interaction
Interaction

IC90-1
IC90-2
IC90-3
IC90-4
IC90-5

Interacting
QTL

Best locus
(cM)a

Peak range
(cM)

Closest
marker

Allele associated with
higher QN IC90

QN IC90 at closest
marker (mean, SD)b

Pc

QN IC90-2
QN IC90-1

180
20
60
25
15

155–185
10–30
30–75
5–60
0–50

C13M56
pfcrt
B5M86
B5M74
C9M57

D
D
H
DxD
DxD

628
613
548
718
829

0.0001
0.0005
0.09d
0.002
<0.0001

(222)
(228)
(231)
(203)
(148)

a. Based on a 5 cM grid.
b. Mean QN IC90 values and standard deviations (nM) of progeny containing the indicated marker (or marker combination). Mean QN IC90 for
entire population: 491 ± 219 nM.
c. P-values are based on Student's t-tests comparing group means of progeny containing the D or H marker of the indicated QTL. Interaction
P-values compare the H and D marker group means for each interacting locus (B5M74 or C9M57) when the Dd2 allele is present at the main
effect locus (pfcrt or C13M56 respectively).
d. Calculations with a model incorporating QTL 1 and 2 yielded a P-value of 0.0005 when the H and D B5M86 marker groups were compared.
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Table 4. Calculations of fit for QTL model of QN response.a
Source

d.f.b

SSc

Adj. SSd

%e

Ff

Pg

Coef h

SEi

B5M86
B5M74
pfcrt
C9M57
C13M56
B5M74 ¥ pfcrt
C9M57 ¥ C13M56
Residual
Total

1
1
1
1
1
1
1
29
36

44 912.6
36 670.5
214 435.8
25 610.2
90 937.0
63 521.9
15 206.0
78 968.1
570 262.0

21 227.4
2 131.4
50 650.6
30 975.6
93 678.2
12 313.8
15 206.0

3.7
0.4
8.9
5.4
16.4
2.2
2.7

7.8
0.78
18.6
11.4
38.4
4.5
5.6

0.009
0.384
0.0001
0.002
0.000002
0.042
0.025

-103.5
32.3
155.2
118.3
198.4
193.4
207.9

37.3
36.7
36.0
35.1
33.9
90.9
89.3

a. Regression variables were coded as described previously (Kim et al., 2001).
b. One degree of freedom (d.f.) was allowed in the test of each term under type III calculations that assume that all other contributing QTL are
correct.
c. SS is the associated sum of squares.
d. Adj. SS is the adjusted sums of squares (type III sum of squares adjusting for all other terms in the model).
e. % is the total variation present in the adjusted sums of squares.
f. F-statistic is based on the adjusted sums of squares.
g. P-values derive from the F distribution.
h. Coef is the estimated effect size of the QTL. An estimated main effect of -103.5 implies that, after adjusting for all other terms in the model,
the effect of inheriting the Dd2- versus the HB3-type B5M86 marker is to decrease the QN IC90 by 103.5 nM. A pairwise interaction coefficient of
193.4 between two markers implies that the effect of a Dd2-type first marker when the second marker has the Dd2 type is to increase the QN
IC90 by 193.4 nM, compared with the effect of a Dd2-type first marker when the second marker is HB3 type.
i. SE is the standard error of this estimate.

rations for four centuries. Malaria parasite strains with
reduced QN sensitivity have been reported from different
malarious regions only since the beginning of the twentieth century (Nocht and Werner, 1910; James et al., 1932;
Clyde et al., 1970). Today, despite the reduced drug sensitivity of some strains in South America and south-east
Asia, all strains remain treatable with dosing regimens that
include an increased QN concentration and a second drug
for radical cure. This pattern is in stark contrast to that of
the global sweep of resistance to CQ: within a few
decades of chloroquine's introduction at the end of the
World War II, fully CQ-resistant P. falciparum strains
spread from at least five foci into nearly all malarious
regions (Wootton et al., 2002; Chen et al., 2003). The slow
progression towards QN resistance reflects more complex
underlying genetic changes in response to the selective
drug pressure than was required for CQR.
Our results assign >95% of the CQR phenotype in the
HB3 ¥ Dd2 cross to a sharp peak on Chr 7 (LOD score
>15; Fig. 2C). This peak contains pfcrt, the determinant of
CQR, as demonstrated by linkage analysis and gene complementation (Fidock et al., 2000), drug selection studies
(Cooper et al., 2002), population studies (Wootton et al.,
2002), direct allelic modification (Sidhu et al., 2002) and
clinical outcome trials (Djimdé et al., 2001). QN response
in the same cross, in contrast, is controlled by multiple
genes and shows no overwhelming influence by a single
locus. Our model incorporates three additive effects, one
of which is the Chr 7 peak containing pfcrt, and two
pairwise interactions from a total of five QTL (Table 4).
Such a multicomponent phenotype in the HB3 ¥ Dd2
cross is consistent with the pattern observed in the field:
© 2004 Blackwell Publishing Ltd, Molecular Microbiology, 52, 985–997

QN continues to be effective against CQR and mefloquine-resistant P. falciparum in spite of likely subsets of
shared genes controlling these responses. That is, the
pfcrt and pfmdr1 genes associated with CQ and mefloquine resistance in a variety of laboratory and field studies
can affect dose–responses and still not lead to high-level
QN-resistant phenotypes, depending on the local selection history, multigene context and genetic background in
which these mutations function.
While the gene mutations that can influence QN
response in the Chr 7 and Chr 5 loci include pfcrt and
pfmdr1, the Chr 13 peak is new and an effector gene
remains to be identified. Approximately 100 genes are
present within the 95% CI QTL peak, one of which
encodes the probable sodium-hydrogen exchanger
PfNHE-1. A sodium-hydrogen exchanger was previously
postulated to mediate CQR, based on the kinetics of drug
uptake and its inhibition by amiloride derivatives (Sanchez
et al., 1998). Although its relationship to QN response was
not examined, drug resistance in CQR parasites was
attributed to elevated cytoplasmic pH values from a constitutively activated NHE (Wunsch et al., 1998); however,
subsequent experiments using sodium-free buffer that
presumably shut down the exchanger found no dependence of CQ uptake on exogenous sodium. Moreover,
amiloride derivatives were shown to alter CQ uptake by
blocking CQ–haem binding rather than by inhibiting NHE
activity (Bray et al., 1999). This evidence that NHE activity
does not underpin CQR is consistent with our finding that
PfCRT variants are central to CQR and that PfCRT is not
an NHE homologue (Wellems et al., 1998). With regard to
QN response in the HB3 ¥ Dd2 cross, however, the pres-
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ence of pfnhe-1 in the Chr 13 QTL peak, along with our
observed statistical correlation in global parasite populations, could revive the possibility of a role for this gene
and its interacting QTL in Chr 9. Genetic transformation
techniques will be required to dissect the Chr 13 QTL and
to test for a role for PfNHE-1 in QN response variation.
Our studies indicate that complete dissection of these
QTL effects will require experimental designs addressing
the need to account for multiple genes from different chromosomes working in combination.
As QN response is a complex trait that includes multiple
modifiers and paired interactions with other loci, a single
genetic cross may capture only a subset of the genetic
components that exist in the general population. Depending on genetic background effects associated with distinct
geographies and drug selection histories, QTL from different regions may vary dramatically in their contributions to
the phenotype of QN response. This is consistent with
reports of candidate genes underlying certain quantitative
traits that have been difficult to dissect in other systems
(Steinmetz et al., 2002). The results of our population
survey of parasite strains from south-east Asia, Africa and
South America support a model in which multiple genes
can combine in different ways to produce similar phenotypes of reduced QN response, as has been suggested
recently in a study using outbred parasite isolates to
examine drug response associations with transporter
gene mutations (Mu et al., 2003). Such a model incorporates a requirement for mutations in multiple loci and may
preclude jumps to clinical levels of QN resistance such as
have occurred against other antimalarial drugs as a result
of mutations in single genes. Further characterizations of
QN response determinants may provide ways to monitor
for incipient resistance in multiple loci and support action
against QN-resistant strains should they arise.
This first use of QTL mapping in P. falciparum demonstrates how QTL mapping can provide a critical layer of
information to an integrated genomics approach for
dissecting the molecular components of complex
phenotypes. In addition to identifying loci, QTL mapping
methods can highlight the broader genetic architecture by
specifying the number of genes and the relative contributions of the specific parental alleles as well as how the
genes may be interacting. This strategy in turn provides a
context for understanding mutations in populations and for
designing appropriate functional gene manipulation
experiments.
Experimental procedures

et al., 1976; Trager and Jensen, 1976). Red blood cells
(RBCs) were purified from leucocytes and platelets by Sepacell R-500II sets (Baxter, Fenwal Division) and suspended
in complete medium [CM; RPMI 1640 with L-glutamine (Life
Technologies), 370 mM hypoxanthine (Hx) and 25 mM
Hepes; 0.5% Albumax I (Life Technologies), 10 mg ml-1 gentamicin and 0.225% NaHCO3) at 4% haematocrit. Cultures
were maintained in six-well plates at 37∞C under an atmosphere of 5% CO2/5% O2/90% N2 in environmental chambers
(Billups-Rothenberg). Parasites recovered from cryopreservates were cultivated for at least three cycles to ascertain
thriving growth with a minimum doubling of parasitaemia in
each 48 h period before assays. The parasite stages in these
cultures were generally synchronous as a result of ring stagespecific survival from the freeze–thaw process. Samples for
drug assays were diluted from cultures consisting of >75%
ring stages.
Drug assays are sensitive to variations in haematocrit,
starting parasitaemia, medium constituents (especially different sources of serum, when used), pH and parasite life cycle
stage (Bickii et al., 1998; Duraisingh et al., 1999). We minimized these sources of non-heritable variation by the following precautions: Albumax from the same lot was used as a
serum substitute; RBCs from one of two donors and CM were
prepared in bulk and used within 1 and 2 weeks respectively;
media stocks were refreshed with gas mixture daily to limit
pH variation; after smear preparation, medium was changed
and cultures were returned to gassed incubator chambers at
37∞C for 2 h before initiating tests; Dd2 and HB3 parental
lines were included in each test as internal controls; up to
nine parasite clones at carefully established parasitaemias
were tested simultaneously and housed in the same environmental chamber; assays of each line were replicated on
different occasions with cultures originating from at least two
separate frozen stocks thawed several weeks apart. Drug
stocks (1 mg ml-1) of QN hydrochloride, CQ diphosphate and
VP hydrochloride were prepared in tissue culture-grade dimethyl sulphoxide (DMSO) or 70% ethanol (Sigma) and preserved at -70∞C until use. Dilutions from these stocks were
established in modified low-hypoxanthine CM (low-Hx CM;
RPMI 1640 with L-glutamine, 2.94 mM Hx and 50 mM Hepes;
0.5% Albumax I, 10 mg ml-1 gentamicin and 0.225%
NaHCO3). Drug assays based on [3H]-hypoxanthine incorporation (Desjardins et al., 1979) were conducted in flatbottomed 96-well plates (Corning Life Sciences). Control
wells in each assay included: parasitized RBCs in CM without
QN, CQ or VP; unparasitized RBCs in CM; and parasitized
RBCs in CM containing 0.89 mM VP (no QN or CQ). Cells
from the wells were lysed after 64–68 h by freezing and
thawing, transferred onto glass fibre filtermats, placed in
sample bags containing scintillation fluid and counted using
a 1450 Micro beta plate reader (Perkin-Elmer Life Sciences).
Counts per minute (c.p.m.) from all test wells were adjusted
by subtracting the counts from RBC-only control wells. Percentage inhibition was calculated by the formula:

Dose–response assays

100 ¥ [(c.p.m. of no drug control)-(c.p.m. of treated sample)]/
(c.p.m. of no drug control).

Clones from the genetic cross between the Dd2 clone from
Indochina and the HB3 clone from Honduras (Wellems et al.,
1990) were cultivated in vitro by standard methods (Haynes

IC50, IC90, slope values and confidence intervals (CI) were
computed from the sigmoid dose–response curves derived
from fitting a three-parameter Hill function (Hill 3 equation
© 2004 Blackwell Publishing Ltd, Molecular Microbiology, 52, 985–997
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from SigmaPlot; SPSS) to the data from repeated assays. VP
chemosensitization ratios were computed from the IC50 and
IC90 values in the presence and absence of 0.89 mM VP.
Mean values used for genome scanning were calculated from
7 to 22 independent assays of each progeny clone, 65 assays
of the Dd2 parent and 53 assays of the HB3 parent.

Genome-wide scans
QTL analysis was carried out by computational approaches
described previously (Sen and Churchill, 2001). The erythrocyte stages of the parasites used for genotyping and phenotyping are haploid; consequently, only two genetic classes
are present for each locus, and the computational approach
is equivalent to an analysis of recombinant inbred lines. Programs (http://www.jax.org/research//churchill) were run under
the MATLAB package (MathWorks), and interval mapping was
carried out at the average resolution (5 cM) of the P. falciparum genetic linkage map (Su et al., 1999) (http://
www.ncbi.nlm.nih.gov/Malaria/Index.html). This resolution
ensured that each mapping interval closely corresponded to
a mapped microsatellite marker. Significance thresholds for
all genome scans were determined by permutation analyses
(Churchill and Doerge, 1994; Lander and Kruglyak, 1995).
Because our set of progeny showed regions of skewed
parental allele inheritance (Su et al., 1999), this permutation
analysis helped to ensure that drug response loci were not
falsely assigned to chance marker arrangements in the pedigree. Main QTL and corresponding mean trait values from
the primary scans were used to obtain estimates of residual
empirical thresholds (Doerge and Churchill, 1996) to search
by secondary scans for additional QTL. This secondary scan
procedure was equivalent to installing the a priori QTL as
covariates, thereby attributing a large portion of the overall
variation to these QTL and allowing for detection of additional
loci controlling the remaining variation.

Pairwise scans
To search for QTL affecting the QN phenotype only in the
context of specific variants at second loci, we performed
pairwise scans at 5 cM spacing, testing all possible pairs of
QTL locations. The likelihood calculated for each pair (two
main loci and an interaction term) was compared with that of
the null model (no pairwise effects). Significance was
assessed by permutation analysis of every pairwise combination of marker alleles. Where an interaction was identified,
a sequential series of statistical tests was performed to distinguish a true epistatic interaction from additive effects (independent gene actions) and hitchhiking (false positives
resulting from related genotypes). These subsequent tests
used a stringent nominal (comparison-wise) cut-off
(P = 0.01).

Statistics
S-PLUS 2000 (Insightful) statistical analysis software was
used to compute correlation coefficients and linear regression analyses of phenotype relationships. An ANOVA for the
final model was conducted by incorporating into a multiple
regression all the main and interacting QTL identified by the
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main, secondary and pairwise scans. F-statistics were calculated from adjusted (type III) sums of squares to make
final determinations on the contribution of a QTL (or interaction) in combination with all other QTL. For this analysis,
inheritance of the Dd2 parent allele was coded as +0.5 and
inheritance of the HB3 parent allele was coded as -0.5 in
the regression analysis. Accordingly, the main effect estimate for any locus was taken to be the difference between
the effect of the Dd2 genotype and the HB3 genotype. Each
interaction parameter was computed from the different
effects on a main QTL of its paired Dd2- or HB3-type interacting QTL.
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